# Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced Pancreatic Cancer

> **NCT00463840** · PHASE1,PHASE2 · TERMINATED · sponsor: **NYU Langone Health** · enrollment: 24 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DRUG:** Oxaliplatin
- **DRUG:** 5FU
- **RADIATION:** Radiation
- **PROCEDURE:** Surgery
- **DRUG:** FOLFOX 6

## Key facts

- **NCT ID:** NCT00463840
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-06
- **Primary completion:** 2010-07
- **Final completion:** 2015-10
- **Target enrollment:** 24 (ACTUAL)
- **Why stopped:** Due to slow accrual
- **Last updated:** 2017-12-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00463840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00463840, "Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced Pancreatic Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00463840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*